ClinConnect ClinConnect Logo
Search / Trial NCT02225938

ICU Recovery in Australian Patients

Launched by AUSTRALIAN AND NEW ZEALAND INTENSIVE CARE RESEARCH CENTRE · Aug 25, 2014

Trial Information

Current as of July 01, 2025

Completed

Keywords

Intensive Care Recovery Long Term Outcome Function

ClinConnect Summary

The ICU Recovery program will measure psychological, functional and cognitive function and quality of life with health economic outcomes in critically ill patients 6 months after ICU admission. The initial pilot study will determine feasibility of the patient outcomes and measurement methods used. The study will consist of patients from three (3) Monash Partners ICUs (2 public and 1 private) as well as The Austin Hospital ICU. 10,000 ICU patients are managed by Monash Partners Academic Health Science Centre (MPAHSC) public and private hospitals each year, of which in the region of 8,500 pat...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • ICU patients who have been invasively mechanically ventilated for over 24 hours
  • Exclusion Criteria:
  • Patients aged less than 18 years old
  • A proven or suspected acute primary brain process that is likely to result in global impairment of conscious level or cognition (e.g. traumatic brain injury, subarachnoid haemorrhage, stroke or hypoxic brain injury after cardiac arrest)
  • Second or subsequent admission to ICU during a single hospital admission
  • Death is deemed imminent and inevitable
  • Participants who do not speak English

About Australian And New Zealand Intensive Care Research Centre

The Australian and New Zealand Intensive Care Research Centre (ANZIC-RC) is a leading research organization dedicated to improving outcomes in critically ill patients through innovative clinical trials and research initiatives. Based at Monash University, the Centre fosters collaborative partnerships among clinicians, researchers, and institutions across Australia and New Zealand. Its focus on evidence-based practice and translational research aims to enhance the quality of intensive care, drive advancements in treatment protocols, and ultimately improve patient care in the intensive care unit (ICU) setting. ANZIC-RC is committed to addressing key challenges in critical care medicine, ensuring that findings from its trials contribute to better health outcomes and inform clinical guidelines globally.

Locations

Melbourne, Victoria, Australia

Malvern, Victoria, Australia

Clayton, Victoria, Australia

Richmond, Victoria, Australia

Heidelberg, Victoria, Australia

Patients applied

0 patients applied

Trial Officials

Carol Hodgson, PhD MRes

Principal Investigator

ANZIC-RC

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials